Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2022-06
ALKERMES USD 288.37M 635K 2023-09
Biogen USD 6.79B 1.8M 2023-12
Bristol-Myers Squibb USD 32.14B 2.52B 2023-09
Cytokinetics USD 607.37M 1.65M 2023-12
Esperion Therapeutics USD 261.16M 427K 2023-09
Gilead Sciences USD 23.19B 1.98B 2023-09
Halozyme Therapeutics USD 1.5B 1.63M 2023-12
Intra Cellular Therapies USD 0 0 2022-06
J&J USD 26.05B 7.85B 2023-09
Marinus Pharmaceuticals USD 64.78M 3.35M 2023-09
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Prothena USD 0 0 2022-06
RedHill Biopharma USD 994K 5.02M 2023-06
Supernus Pharmaceuticals USD 0 400.38M 2022-06
United Therapeutics USD 300M 200M 2023-12



Intra Cellular Therapies Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.